Point of Care Diagnostics Market Size, Share, Growth Analysis and Forecast to 2034

According to Fortune Business Insights, the global point of care diagnostics market size was valued at USD 32.87 billion in 2025 and is projected to grow from USD 34.47 billion in 2026 to USD 60.36 billion by 2034, exhibiting a CAGR of 7.26% during the forecast period.

The global point of care (POC) diagnostics market is witnessing robust growth due to rising demand for rapid and accurate diagnostic solutions at or near patient care settings. Point-of-care diagnostics enable healthcare professionals to deliver immediate results, reducing dependency on centralized laboratories and improving clinical decision-making.

Information Source: https://www.fortunebusinessinsights.com/industry-reports/point-of-care-diagnostics-market-101072 

Market Drivers

One of the primary drivers of the market is the increasing prevalence of chronic and infectious diseases such as diabetes, cardiovascular disorders, and respiratory infections. These conditions require frequent monitoring, which boosts the adoption of portable diagnostic devices.

Additionally, the growing geriatric population globally is contributing significantly to market expansion. Elderly individuals are more prone to chronic diseases, increasing the need for continuous and convenient diagnostic testing.

The shift toward decentralized healthcare systems is another major factor. Healthcare providers are increasingly adopting point-of-care solutions in clinics, home care settings, and remote areas to enhance accessibility and reduce hospital burden.

Technological advancements, including microfluidics, biosensors, and digital health integration, are further accelerating market growth. These innovations enable faster, more accurate, and user-friendly diagnostic tools.

Market Restraints

Despite strong growth prospects, the market faces certain challenges. High costs of advanced diagnostic devices and limited reimbursement policies in developing regions can restrict adoption.

Moreover, concerns regarding accuracy and reliability compared to laboratory-based tests may hinder widespread use. Regulatory complexities associated with approvals of diagnostic devices also pose a barrier for new entrants.

Market Segmentation

The point of care diagnostics market is segmented based on product type, sample type, end-user, and region.

By product type, the market includes:

• Glucose monitoring kits

• Infectious disease testing kits

• Cardiac marker testing

• Pregnancy and fertility testing

• Coagulation testing

Among these, glucose monitoring devices hold a dominant share due to the rising global burden of diabetes.

By sample type, the market is categorized into blood, urine, and others. Blood-based testing dominates due to its widespread application in multiple diagnostic procedures.

Based on end-user, the market is divided into:

• Hospitals and clinics

• Home care settings

• Diagnostic laboratories

The home care segment is expected to grow rapidly owing to increasing patient preference for self-testing and remote monitoring.

Regional Insights

North America dominates the global market, accounting for approximately 35.6% share in 2025. This dominance is attributed to advanced healthcare infrastructure, high adoption of innovative technologies, and strong presence of key market players.

Europe holds the second-largest share due to increased healthcare spending and growing awareness regarding early disease diagnosis.

The Asia-Pacific region is expected to witness the fastest growth during the forecast period. Factors such as improving healthcare infrastructure, rising population, and increasing prevalence of chronic diseases are driving demand in countries like China and India.

Competitive Landscape

The global point of care diagnostics market is highly competitive, with several leading players focusing on product innovation, strategic collaborations, and mergers & acquisitions to strengthen their market position.

Key Players:

• Abbott Laboratories

• F. Hoffmann-La Roche Ltd.

• Siemens Healthineers AG

• Danaher Corporation

• Becton, Dickinson and Company (BD)

• QuidelOrtho Corporation

• bioMérieux SA

• Nova Biomedical

• Trinity Biotech plc

These companies are investing heavily in research and development to introduce advanced diagnostic solutions and expand their global footprint.

Industry Trends

A significant trend in the market is the integration of digital technologies such as artificial intelligence and connectivity features into diagnostic devices. These advancements enable real-time data sharing and improved patient monitoring.

Another emerging trend is the growing popularity of at-home testing kits, especially after the COVID-19 pandemic. Consumers are increasingly opting for convenient and quick diagnostic solutions.

Furthermore, miniaturization of diagnostic devices is enabling the development of portable and easy-to-use products, enhancing their adoption in remote and resource-limited settings.

Future Outlook

The future of the point of care diagnostics market looks promising, driven by continuous technological advancements and increasing healthcare demands. The expansion of telemedicine and remote patient monitoring is expected to further boost market growth.